Daunomycinone
CAS: 21794-55-8
Ref. 3D-FD20803
5mg | 146,00 € | ||
10mg | 202,00 € | ||
25mg | 364,00 € | ||
50mg | 485,00 € | ||
100mg | 715,00 € |
Produktinformation
- (8S,10S)-8-Acetyl-7,8,9,10-tetrahydro-6,8,10,11-tetrahydroxy-1-methoxy- -5,12-naphthacenedione(+)-DaunomycinoneDaunomycin aglicone DaunorubicinoneEpirubicin Impurity B
- (+)-Daunomycinone
- (8S,10S)-8-Acetyl-7,8,9,10-tetrahydro-6,8,10,11-tetrahydroxy-1-methoxy-5,12-naphthacenedione
- 5,12-Naphthacenedione, 8-acetyl-7,8,9,10-tetrahydro-6,8,10,11-tetrahydroxy-1-methoxy-, (8S-cis)-
- 5,12-naphthacenedione, 8-acetyl-7,8,9,10-tetrahydro-6,8,10,11-tetrahydroxy-1-methoxy-, (8S,10S)-
- Daunomycin aglicone
- Daunomycinon
- Daunomycinone derivative
- Daunorubicin aglycone
- Daunorubicinone
- Mehr Synonyme anzeigen
- Leukaemomycinone C
- NSC 109351
Daunomycinone is a chemical compound that belongs to the group of antitumor agents. It is used in cancer therapy and has been shown to inhibit protein synthesis, leading to cell death. Daunomycinone can be synthesized by reacting adriamycin with trifluoroacetic acid in the presence of an organic base. This reaction produces a daunomycinone molecule that has a hydroxyl group at one end and a carbonyl group at the other. The binding constants between daunomycinone and human serum proteins have been determined experimentally using molecular modeling techniques. Hydrogen bonding interactions are also present in this complex, which may account for its high affinity for proteins found in human serum.
Chemische Eigenschaften
Technische Anfrage zu: 3D-FD20803 Daunomycinone
Wenn Sie ein Angebot anfordern oder eine Bestellung aufgeben möchten, legen Sie stattdessen die gewünschten Produkte in Ihren Warenkorb und fordern Sie dann ein Angebot oder eine Bestellung an aus dem Warenkorb. Es ist schneller, billiger und Sie können von den verfügbaren Rabatten und anderen Vorteilen profitieren.